AGP Executive Report
Last update: 8 hours agoDrug Pricing & Access: Illinois passed bills aimed at protecting hospitals’ access to discounted 340B drugs while also ordering an audit of how providers use 340B profits. Regulation Watch: Hong Kong will regulate medical gases as pharmaceutical products starting June 14, requiring licensing and registration. Obesity Treatment Shift: The UK approved Novo’s oral weight-loss pill (semaglutide), giving patients an injection alternative and raising questions about access and long-term adherence. Cancer Care Quality: Dutch researchers found only about one in three eligible breast cancer patients received a test that can help avoid unnecessary chemotherapy. Supply & Shortages: India approved price hikes for key cancer drugs (cisplatin, carboplatin) and tetanus immunoglobulins after West Asia conflict disrupted API supplies. Diagnostics Expansion: Thyrocare opened a new lab in Prayagraj with SecondMedic to expand diagnostic access. Public Health Alerts: Kerala confirmed a suspected Nipah case in Kozhikode and began contact tracing. Health Equity: A study found major racial/ethnic gaps in diabetes screening and annual exam completion. Biomarker Breakthrough: A plasma GFAP test showed strong accuracy for mild traumatic brain injury in older adults.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
